Comparative effect of metformin versus sulfonylureas with dementia and Parkinson's disease risk in US patients over 50 with type 2 diabetes mellitus.
BMJ Open Diabetes Res Care
; 10(5)2022 09.
Article
in En
| MEDLINE
| ID: mdl-36109050
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Dementia
/
Diabetes Mellitus, Type 2
/
Metformin
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMJ Open Diabetes Res Care
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: